Everolimus-Eluting versus Paclitaxel-Eluting Stents in Percutaneous Coronary Intervention: Meta-Analysis of Randomized Trials

Background. Individual randomized trials have suggested that everolimus-eluting stents may have improved clinical outcomes compared to paclitaxel-eluting stents, but individual trials are underpowered to examine outcomes such as mortality and very late stent thrombosis. Methods. Medline, Cochrane, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alazzoni, Ashraf, Al-Saleh, Ayman, Jolly, Sanjit S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357603/
https://www.ncbi.nlm.nih.gov/pubmed/22655192
http://dx.doi.org/10.1155/2012/126369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357603/
https://www.ncbi.nlm.nih.gov/pubmed/22655192
http://dx.doi.org/10.1155/2012/126369

Ejemplares similares